C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 261/20 (2006.01) A61K 31/215 (2006.01) A61K 31/27 (2006.01) A61K 31/42 (2006.01) A61P 31/16 (2006.01) C07C 233/52 (2006.01) C07C 271/24 (2006.01) C07C 279/16 (2006.01) C07C 279/24 (2006.01) C07C 309/66 (2006.01)
Patent
CA 2315262
Compounds represented by the formulae: (see formula I), (see formula II), or (see formula III) wherein U is CH, O, or S; Z is -C(R2)(R3), -CH-N(R2)(R3), C(R3)[(CH2)n R2], CH-C(R3)(R8)(CH2)n R2, C[(CH2)n R2]-[CH(R3)(R8)], C[(R3)][CH[(CH2)n R2](R8)]; R1 is H, (CH2)n OH, (CH2)n NH2, (CH2)n NR10R11, (CH2)n OR11, (CH2)n SR11, or (CH2)n halogen R9 is (CH2)n CO2H, (CH2)n SO3H, (CH2)n PO3H2, (CH2)n NO2, CH(SCH3)3, esters thereof, or salts thereof; or R1 R9 together represent = O, or (see formula IV) R2 is H, NHC(O)R5, NHC(S)R5, NHSO2R5, C(O)NHR5, SO2NHR5, CH2S(O)R5, or CH2SO2R5 R3 and R8 individually is H, (CH2)n C(O)R10, (CH2)n CO2R10, (CH2)m OR10, CH(OR10)CH(R10)m, C(O)N(R10)m, C(O)N(OR10)R10, (CH2)n N(R10)m, CH(R10)m, (CH2)n(R10)m, , CH2CH(OR10)CH2OR10, CH(OR10)CH(OR10)CH2OR10, CH2OR10, CH(OR10)CH2NHR10, CH2CH(OR10)CH2NHR10, CH(OR10)CH(OR10)CH2NHR10, C(=NR10)N(R10)m, NHR10, NHC(=NR10)N(R10)m, (CH2)m-X-W-Y, CH2CH(X-W- Y)CH2OR10, CH(X-W-Y)CH(OR10)CH2OR10, CH(X-W-Y)CH2(OR10), CH(OR10)CH(X-W-Y)CH2OR10, CH(OR10)CH2(X-W-Y), CH2CH(X-W- Y)CH2NHR10, CH(X-W-Y)CH(OR10)CH2NHR10, CH(X-W-Y)CH2(NHR10), CH(OR10)CH(X-W-Y)CH2NHR10, or CH(NHR10)CH2(X-W-Y); provided that at least one of R2, R3, and R8 is other than H; R4 is H, (CH2)n OH, (CH2)n OR11, (CH2)n OC(O)R11, (CH2)n NHC(NR11)NHR11, (CH2)n NR10R11, (CH2)n NH2, (CH2)n C(=NH)(NH2), (CH2)n NHC(=NR11)NH2, (CH2)n NHC(=NR7)NH2, (CH2)n CN, (CH2)n N3, C(=NH)NH2, C(NR7)NH2, or C(NR11)NH2; R5 is H, lower alkyl, cyclo alkyl, halogen substituted alkyl, aryl, substituted aryl, or CF3; R7 is H, (CH2)n OH, (CH2)n CN, (CH2)n NH2, or (CH2)n NO2; R10 is H, lower alkyl, lower alkylene, branched alkyl, cyclic alkyl, (CH2)n aromatic, (CH2)n substituted aromatic, or when m is 2 both R10 groups can also be interconnected to form an N substituted heterocyclic ring, or other 5 or 6 membered heterocyclic ring; R11 is lower alkyl, branched alkyl, (CH2)m aromatic, SO2R10, C(O)R10, or C(O)OR10; R12 and R13 is H, (CH2)n OH, (CH2)n NH2, (CH2)n NR10R11, (CH2)n OR11, (CH2)n F, (CH2)n OC(O)R11, (CH2)n NHC(O)R11, or X-W-Y; m is 1 or 2; n is 0-4; p is 0 or 1; X is O, S, CH2, or NH; W is a spacer group made up of a chain of 1 to 100 atoms, and optionally also comprising of substituted carbon and/ or nitrogen atoms and optionally including oxygen or sulphur atoms; and Y is H, OH, SH, NH2, CH=O, CH=CH2, CO2H, CONHNH2, or a protected form of one of these end functionalities; and pharmaceutically aceptable salts thereof and their method of preparation are provided. Compounds of the above formula are influenza virus nueraminidase inhibitors and can be used in treating patients infected with influenza virus. Also provided are intermediates represented by the formulae:. Another aspect of the present invention relates to intermediates represented by the following formulae: (see formula V) Wherein R4 and R9 are the same as defined above; and (see formula VI) Wherein each R14 individually is H, O, (CH2)n CO2H, (CH2)n SO3H, (CH2)n PO3H, (CH2)n NO2, CH(SCH3)3, (see formula IV) esters thereof or salts thereof, and provided at least one of R14 is H, and R3 and R4 are as defined above.
La présente invention concerne des composés représentés par les formules générale (I, II, III), ainsi que certains de leurs esters ou de leurs sels. Dans ces formules U est CH, O, ou S; Z est -C(R2)(R3), -CH-N(R2)(R3), C(R3)[(CH2)nR2], CH-C(R3)(R8)(CH2)nR2, C[(CH2)nR2]-[CH(R3)(R8)], C[(R3)][CH[(CH2)nR2](R8)]; R1 est H, (CH2)nOH, (CH2)nNH2, (CH2)nNR10R11, (CH2)nOR11, (CH2)nSR11, ou (CH2)n halogène; R9 est (CH2)nCO2H, (CH2)nSO3H, SO3H, (CH2)nPO3H2, (CH2)nNO2, CH(SCH3)3.
Babu Yarlagadda S.
Chand Pooran
Montgomery John A.
Biocryst Pharmaceuticals Inc.
Moffat & Co.
LandOfFree
Substituted cyclopentane and cyclopentene compounds useful... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclopentane and cyclopentene compounds useful..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclopentane and cyclopentene compounds useful... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2045996